OR WAIT null SECS
Industry news focusing on the people and organizations who work in the clinical trials profession.
• Chiltern International Limited (Chiltern) (London, UK and Wilmington, NC) announced the appointments of Maneula Niewel, MD, and Lisa Bull. Niewel has been appointed Medical Director to serve as therapeutic expert in the oncology area in the medical department. Bull has been appointed Director of Strategic Partnerships in the Business Development function.
• Medidata Solutions (New York, NY) announced that Steven Wilhite, a business leader and marketing executive with more than 25 years of experience building global brands, has been named Chief Marketing Officer and Executive Vice President. Wilhite will be responsible for all global marketing activities for the company, a provider of cloud-based solutions for the life sciences industry.
• Theorem Clinical Research (King of Prussia, PA) announced Connie Wierman, a seasoned executive with more than 25 years of biopharmaceutical experience, has been named Vice President of Biopharmaceutical Development. She leads the company's oncology therapeutic focus for the biopharmaceutical business unit.
• Novella Clinical, (Research Triangle Park, NC) a full service clinical research organization, announced two new hires to supplement business development efforts on the West Coast. Carole Gabos and Jeremie Braun joined as Directors of Client Business Development.
• CRI Lifetree (Salt Lake City, UT) Chief Medical Director and Co-Founder of Lifetree Clinical Research, Lynn Webster, MD, has been elected President of the American Academy of Pain Medicine, the medical specialty society representing physicians practicing in the field of pain medicine. As a medical specialty society, the organization is involved in education, training, advocacy, and research in the specialty of pain medicine.
• Synexus (Manchester, England) CEO, Christophe Berthoux, DVM, MBA, has spearheaded a complete overhaul of the company's management structure over the last two years. The Synexus Global Executive Team is comprised of: Berthoux, DVM, MBA, Chief Executive; Jane Restorick, Chief Operating Officer; Chris Hannigan, Commercial Director; Paul Chambers, Chief Financial Officer; Glynis Neagle, MD, Chief Medical Officer; and Wendy Ingham, Group Human Resources Director. Supporting them is the Global Management Team of: Alison Martin, VP International Projects; Tony Healy, Group IT Director; and Janet Jones, VP Access to Patients. A new regional structure—reporting to Restorick—is headed by regional directors who are responsible for the day to day running of the dedicated research centers in their territories, new business and profitability. Klaus-Dieter Albrecht, Managing Director of Synexus Germany, is responsible for the management of the seven Synexus dedicated clinical trial centers in Germany. Sanet Aspinall, MD, Managing Director of Synexus South Africa, is responsible for the two centers in South Africa. Radoslaw Janiak, MD, is Managing Director of Synexus Central and Eastern Europe with responsibility for eight centers in Poland, Bulgaria, Ukraine, and Hungary. Angela Harnick is Operational Director of the United Kingdom, responsible for seven centers across England, Wales, and Scotland.
• The Alliance for Clinical Research Excellence and Safety (Cambridge, MA) announced its new Board of Directors, as well as the appointment of a Global Advisory Board. The Directors are: Bill Davenhall, Senior Health Advisor, Health and Human Services at ERSI; Jose-Luiz Gomes do Amaral, MD, Professor, Federal University of Sao Paulo, Brazil and immediate Past-President of the World Medical Association; Ragna Krishnan, MD, Dean, Duke-National University of Singapore Graduate School of Medicine, and Professor and Chair, Department of Psychiatry, Duke University School of Medicine; Rebecca Kush, PhD, Founder and President, Clinical Data Interchange Standards Consortium; Kenneth E. MacWilliams, Chief Executive Officer at Woodrow Wilson Associates, former President of Prudential Capital Corporation; Briggs Morrison, MD, Executive Vice President, Global Medicines Development and Chief Medical Officer, AstraZeneca; M. Roy Schwarz, MD, former Dean of the University of Colorado School of Medicine, Vice Chancellor for Academic Affairs at the University of Colorado Health Sciences Center and Senior Vice President of Medical Education and Science at the American Medical Association, former President, China Medical Board of New York; and Eve E. Slater, MD, Associate Professor of Clinical Medicine, Columbia University, formerly the Senior Vice President, Worldwide Policy at Pfizer, and Senior Vice President for External Policy at Merck, former Assistant Secretary for Health, US Department of Health and Human Services. The Board will also include, as ex officio, non-voting members and corporate officers, the three ACRES Co-Founders: Greg Koshi of Harvard University, former Director of the US Office for Human Research Protections; Beat Widler, Partner at Widler and Schiemann, Ltd, former Head of Global Quality for Hoffman-La Roche; and Andre Olmsted, Executive Vice President of Research Dataware. In addition to the Board of Directors, the Global Advisory Board will guide the development of the ACRES Global Network through implementation of its foundation initiatives. Advisors include leaders of ACRES' regional presence, Jean-Paul Deslypere (Asia), Joao Massud (Latin America), and Norbert Clemens (Europe), along with key thought-leaders Steve Sonstein (Eastern Michigan University and the Consortium of Academic Programs in Clinical Research), Craig Lipset (Pfizer), Alberto Grignolo (Parexel), Peter Alterman (SAFE-BioPharma), Guy Mascaro (Metrics Champion Consortium), Al Pacino (HealthCare Point), and independent life-sciences attorney, Leslie Platt (Leslie Platt and Associates, LLC). The Advisory Board will be chaired by ACRES' Vice President for System Integration and Professionalism, Honorio Silva, MD, formerly Vice-President for Science and Medical Professional Development at Pfizer and current President of the Inter-American Foundation for Clinical Research.
• Advanced Clinical (Deerfield, IL) announced Julie A. Ross joined its leadership team as Executive Vice President, CRO Operations.
• Celerion (Lincoln, NE) announced the appointment of Bruce Morimoto, PhD, as Executive Director of Applied Translational Medicine. Morimoto will have responsibility for developing and implementing strategies for patient populations in early clinical research and clinical pharmacology studies.
• The Altasciences Group (Laval, Québec, Canada) announced the addition of Vince and Associates Clinical Research to its team providing comprehensive Phase I/IIa clinical drug development capabilities.
• Sitrof Technologies, (Princeton, NJ) a provider of IT and document management solutions for the life sciences industry, announced that the EMC Information Intelligence Group (IIG) has recognized the company with an IIG Partner Innovation Award, presenting it with the Outstanding Industry Solution for Life Sciences Award for its Safety Capture solution. The IIG Partner Innovation Awards for the Americas recognize key partners for excellence and innovation in solution development, design integration, and best practices for implementation and deployment.
• ICON plc (Dublin, Ireland) has received the 2013 "Partnership Pioneers of the Year" award in recognition of its strategic partnership with Pfizer and PAREXEL. Presented by the Institute for International Research and Partnerships in Clinical Trials' advisory board, the award recognizes two or more companies engaged in a partnership that moves beyond the traditional transactional model to a more strategic approach that can bring innovation to the drug development process.
• Pharmaceutical Product Development, LLC (PPD) (Wilmington, NC) announced that Skillsoft has named PPD a winner of the 2013 Skillsoft Perspectives Innovation Award for Empowering Learning Cultures in the Enterprise. Judged by an independent panel of industry experts, the Skillsoft award honors the organization that best demonstrates the ability to make learning part of the fabric of its operations, empowering employees to take charge of their professional growth and development, promoting knowledge sharing and measuring results.
• INC Research, LLC (Raleigh, NC), a therapeutically focused global clinical research organization, is ranked the "Top CRO" in the 2013 CenterWatch Global Investigative Site Relationship Survey. INC Research received the highest "excellent" scores in six out of seven working relationship categories among all CROs included in the survey.
• Pharmaceutical Product Development, LLC (PPD) (Wilmington, NC) has been named a gold-level Fit Friendly Worksite for 2013 as an employer that excels in promoting healthy employee lifestyle by the American Heart Association. The Fit-Friendly program recognizes employers that champion employees' wellness and work to create a culture of physical activity and health in the workplace by implementing activities outlined by the Association.
• ERT (Philadelphia, PA) announced the addition of local resources to its fully-owned subsidiary, ERT Asia Group, Ltd. The Japan-based project management and business development team will further enhance the quality of centralized services ERT is known for providing throughout Asia. The team will work out of ERT's new office in Ginza, Chuo-ku, Tokyo. The Japan-based operations staff comes primarily from ERT's seven-year partnership with Site Support Institute, a Japanese site management organization and subsidiary of CMIC Holdings Co., Ltd.
• INC Research, LLC (Deerfield, IL) announced it will kick off its 2013 "Perspectives" webinar series with a session focused on clinical innovation. Designed to provide the latest insights on clinical research, the eight-session series will feature industry experts and INC Research thought leaders offering valuable insights and practical knowledge on a range of topics, including strategic data monitoring, site relationships, and more. To view the full "Perspectives" schedule, register for the upcoming sessions, access the 2012 "Perspectives" archive, or submit a topic for a future session, visit www.incresearch.com/perspectives.
• LabConnect (Seattle, WA) announced the expansion of its North American headquarters in Seattle. LabConnect provides central laboratory testing services to the biopharmaceutical industry through a global network of regional and local laboratories.
• Harlan Laboratories (Indianapolis, IN), a contract research organization and research models and services company, announced the expansion of its specialty research production facilities in Indianapolis, IN, and Livermore, CA. This expansion more than doubles the number of isolators at these sites, allowing Harlan to meet growing customer demand for its immunocompromised models.
• BioDuro (Wilmington, NC), a PPD company, announced it has opened a new laboratory in Shanghai, strengthening its ability to provide biopharmaceutical clients a range of customized drug discovery services in Asia Pacific. The 72,000-square-foot lab, accompanied by 20,000 square feet of office space, offers integrated drug metabolism and pharmacokinetic (DMPK), bioanalytical, chemistry, discovery biology, and oncology pharmacology services.
• Greenphire (King of Prussia, PA), a provider of payment technologies for the clinical trials industry, announced an expansion to the European market with the opening of its London, UK office. This addition is a key part of the 2013 strategic plan and is designed to support the increasing global demand for Greenphire's products and services.